Article

A scalable cell-free manufacturing platform for two-step bioproduction of immunogenic conjugate vaccines

2025-08-06

Abstract excerpt

Rapid and decentralized vaccine production is essential to ensure global preparedness against emerging and re-emerging infectious diseases. Cell-free gene expression systems, which can be freeze-dried for long-term storage and re-activated for point-of-use synthesis, offer a promising solution to address this need. However, scalable cell-free production of conjugate vaccines-highly effective tools against bacteria...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 147a2be1-5c33-5371-b718-ff732e31eaa8
DOI: 10.1101/2025.08.05.668792

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A scalable cell-free manufacturing platform for two-step bioproduction of immunogenic conjugate vaccinesDOI 10.1101/2025.08.05.668792Read

A low-cost, thermostable, cell-free protein synthesis platform for on demand production of conjugate vaccinesSemantic proximity Read

Development of a novel glycoengineering platform for the rapid production of conjugate vaccinesSemantic proximity Read

Development of a novel glycoengineering platform for the rapid production of conjugate vaccinesSemantic proximity Read

Emerging Technologies for Low‐Cost, Rapid Vaccine ManufactureSemantic proximity Read

Scalable, methanol-free manufacturing of the SARS-CoV-2 receptor binding domain in engineered <i>Komagataella phaffii</i>Semantic proximity Read

A low-cost recombinant glycoconjugate vaccine confers immunogenicity and protection against enterotoxigenic Escherichia coli infections in miceSemantic proximity Read

Redesigned upstream processing enables a 24-hour workflow from <i>E. coli</i> cells to cell-free protein synthesisSemantic proximity Read

Polysaccharide Conjugate Vaccines: From Historical Milestones to Future StrategiesSemantic proximity Read

Rapid screening and scaled manufacture of immunogenic virus-like particles in a tobacco BY-2 cell-free protein synthesis systemSemantic proximity Read

Techno-Economic Assessment of Cell-Free Synthesis of Monoclonal Antibodies Using CHO Cell ExtractsSemantic proximity Read

Reshaping Cell Line Development and CMC Strategy for Fast Responses to Pandemic OutbreakSemantic proximity Read

Development of a CHO-Based Cell-Free Platform for Synthesis of Active Monoclonal AntibodiesSemantic proximity Read